GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Concord Healthcare Group Co Ltd (HKSE:02453) » Definitions » Operating Income

Concord Healthcare Group Co (HKSE:02453) Operating Income : HK$-370.5 Mil (TTM As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Concord Healthcare Group Co Operating Income?

Concord Healthcare Group Co's Operating Income for the six months ended in Jun. 2024 was HK$-167.7 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Jun. 2024 was HK$-370.5 Mil.

Warning Sign:

Concord Healthcare Group Co Ltd has never been profitable in the past 3 years. It lost money every year.

Operating Margin % is calculated as Operating Income divided by its Revenue. Concord Healthcare Group Co's Operating Income for the six months ended in Jun. 2024 was HK$-167.7 Mil. Concord Healthcare Group Co's Revenue for the six months ended in Jun. 2024 was HK$235.8 Mil. Therefore, Concord Healthcare Group Co's Operating Margin % for the quarter that ended in Jun. 2024 was -71.14%.

Concord Healthcare Group Co's 5-Year average Growth Rate for Operating Margin % was 0.00% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Concord Healthcare Group Co's annualized ROC % for the quarter that ended in Jun. 2024 was -5.13%. Concord Healthcare Group Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was -8.30%.


Concord Healthcare Group Co Operating Income Historical Data

The historical data trend for Concord Healthcare Group Co's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concord Healthcare Group Co Operating Income Chart

Concord Healthcare Group Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Operating Income
-309.05 -477.34 -509.24 -386.83

Concord Healthcare Group Co Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Operating Income Get a 7-Day Free Trial -268.76 -253.20 -184.09 -202.74 -167.72

Concord Healthcare Group Co Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-370.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Concord Healthcare Group Co  (HKSE:02453) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Concord Healthcare Group Co's annualized ROC % for the quarter that ended in Jun. 2024 is calculated as:

ROC % (Q: Jun. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Jun. 2024 ))/ count )
=-335.446 * ( 1 - 1.22% )/( (6347.782 + 6581.178)/ 2 )
=-331.3535588/6464.48
=-5.13 %

where

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=5727.459 - 303.609 - ( 44.382 - max(0, 1317.475 - 393.543+44.382))
=6347.782

Invested Capital(Q: Jun. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=6157.566 - 232.022 - ( 343.088 - max(0, 1384.628 - 728.994+343.088))
=6581.178

Note: The Operating Income data used here is two times the semi-annual (Jun. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Concord Healthcare Group Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Jun. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Jun. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-324.742/( ( (3771.779 + max(-608.262, 0)) + (4055.038 + max(-374.509, 0)) )/ 2 )
=-324.742/( ( 3771.779 + 4055.038 )/ 2 )
=-324.742/3913.4085
=-8.30 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(83.11 + 44.131 + 32.811) - (303.609 + 0 + 464.705)
=-608.262

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(75.249 + 42.881 + 178.371) - (232.022 + 0 + 438.988)
=-374.509

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

3. Operating Income is also linked to Operating Margin %:

Concord Healthcare Group Co's Operating Margin % for the quarter that ended in Jun. 2024 is calculated as:

Operating Margin %=Operating Income (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=-167.723/235.75
=-71.14 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.


Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Concord Healthcare Group Co Operating Income Related Terms

Thank you for viewing the detailed overview of Concord Healthcare Group Co's Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Concord Healthcare Group Co Business Description

Traded in Other Exchanges
N/A
Address
No. 7 Guanghua Road, Room 26A1-26A5, East Tower, Hanwei Building, Chaoyang, Beijing, CHN, 100020
Concord Healthcare Group Co Ltd is a healthcare service provider in China that specializes in oncology. The company caters to both cancer patients and third-party medical institutions. It operates its own medical institutions to provide comprehensive oncology healthcare services to cancer patients using its medical professionals and advanced precision radiation therapy. It also provides medical equipment, software, and related services to third-party medical institutions. The company's revenue is primarily generated from its hospital business and its medical equipment, software, and related services segment.
Executives
Ascendium Group Limited
Concord Medical Services Holdings Limited
Morgancreek Investment Holdings Limited
Yang Jianyu
Zhang Bi
Shanghai Medstar Financial Leasing Company Limited
China International Capital Corporation Limited
Zhong Jin Zi Ben Yun Ying You Xian Gong Si
Zhong Jin Jia Tai Er Qi Tian Jin Gu Quan Tou Zi Ji Jin He Huo Qi Ye You Xian He Huo
Beijing Concord Medical Technology Co., Ltd.
Concord Hospital Management Group Limited
Tianjin Concord Medical Technology Co., Ltd.

Concord Healthcare Group Co Headlines

No Headlines